首页 › 基金 › NEXT CENTURY GROWTH INVESTORS LLC › ADPT
NEXT CENTURY GROWTH INVESTORS LLC 对 ADPT 的持仓历史
ADAPTIVE BIOTECHNOLOGIES COR · 医疗保健
NEXT CENTURY GROWTH INVESTORS LLC 在 Q3 2026 的 13F 申报中披露持有 ADPT(ADAPTIVE BIOTECHNOLOGIES COR)622,894 股,市值约 US$18.0M,约占其申报组合的 1.15%,在其申报持仓中市值排名第 33 位。 NEXT CENTURY GROWTH INVESTORS LLC 最近 5 个申报季度中有 5 个季度披露了 ADPT 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
NEXT CENTURY GROWTH INVESTORS LLC 对 ADPT 的持仓演变
NEXT CENTURY GROWTH INVESTORS LLC 于 Q3 2025 首次披露 ADPT 持仓:531,317 股(约 US$7.9M)。 该持仓在 Q3 2026 达到峰值 622,894 股,市值约 US$18.0M。 在 5 次申报中,NEXT CENTURY GROWTH INVESTORS LLC 3 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 622,894 股、市值约 US$18.0M,环比增持 13,064 股。。 持仓曾出现大幅变动:Q4 2025 增持约 78% (随后一个季度股价下跌 15%)、Q1 2026 减持约 47% (随后一个季度股价上涨 55%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 531.32K | $7.95M | 新进 |
| Q4 2025 | 943.60K | $15.32M | 增持 |
| Q1 2026 | 504.35K | $7.00M | 减持 |
| Q2 2026 | 609.83K | $13.08M | 增持 |
| Q3 2026 | 622.89K | $18.00M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ADPT 与 13F 数据
ADPT(ADAPTIVE BIOTECHNOLOGIES COR)属于医疗保健行业。我们追踪的基金中还有 57 只申报持有 ADPT,申报仓位最大的包括:维京环球投资 (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ADPT 的基金
- 维京环球投资 29.99M 股 · $643.37M · Q2 2026
- VIKING GLOBAL INVESTORS LP 29.99M 股 · $643.37M · Q2 2026
- Aristotle Atlantic Partners, LLC 1.84M 股 · $39.44M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.22M 股 · $26.11M · Q2 2026
- Blue Water Life Science Advisors, LP 1.01M 股 · $21.67M · Q2 2026
- Granite Investment Partners, LLC 628.10K 股 · $18.15M · Q3 2026
- Hillsdale Investment Management Inc. 551.35K 股 · $15.93M · Q3 2026
更多关于 NEXT CENTURY GROWTH INVESTORS LLC
常见问题
How long has NEXT CENTURY GROWTH INVESTORS LLC held ADPT?
NEXT CENTURY GROWTH INVESTORS LLC has disclosed ADPT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is NEXT CENTURY GROWTH INVESTORS LLC's current position in ADPT?
As of Q3 2026, NEXT CENTURY GROWTH INVESTORS LLC holds 622.89K shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $18.00M, representing 1.15% of its reported portfolio and ranking #33.
Has NEXT CENTURY GROWTH INVESTORS LLC been buying or selling ADPT?
In the latest 13F filing (Q3 2026), NEXT CENTURY GROWTH INVESTORS LLC increased its position in ADPT. The position peaked in Q3 2026 at 622.89K shares.
Which other funds hold ADPT?
Other major institutional holders of ADPT include 维京环球投资, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.